Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China; The Fourth Clinical College of Nanjing Medical University, Nanjing, China; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China.
Department of Thoracic Surgery, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, China; Jiangsu Key Laboratory of Molecular and Translational Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Cancer Institute of Jiangsu Province, Nanjing, China.
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1784-1792.e3. doi: 10.1016/j.jtcvs.2017.11.098. Epub 2017 Dec 20.
Postoperative survival of patients with stage IIIA-N2 non-small cell lung cancer (NSCLC) is highly heterogeneous. Here, we aimed to identify variables associated with postoperative survival and develop a tool for survival prediction.
A retrospective review was performed in the Surveillance, Epidemiology, and End Results database from January 2004 to December 2009. Significant variables were selected by use of the backward stepwise method. The nomogram was constructed with multivariable Cox regression. The model's performance was evaluated by concordance index and calibration curve. The model was validated via an independent cohort from the Jiangsu Cancer Hospital Lung Cancer Center.
A total of 1809 patients with stage IIIA-N2 NSCLC who underwent surgery were included in the training cohort. Age, sex, grade, histology, tumor size, visceral pleural invasion, positive lymph nodes, lymph nodes examined, and surgery type (lobectomy vs pneumonectomy) were identified as significant prognostic variables using backward stepwise method. A nomogram was developed from the training cohort and validated using an independent Chinese cohort. The concordance index of the model was 0.673 (95% confidence interval, 0.654-0.692) in training cohort and 0.664 in validation cohort (95% confidence interval, 0.614-0.714). The calibration plot showed optimal consistency between nomogram predicted survival and observed survival. Survival analyses demonstrated significant differences between different subgroups stratified by prognostic scores.
This nomogram provided the individual survival prediction for patients with stage IIIA-N2 NSCLC after surgery, which might benefit survival counseling for patients and clinicians, clinical trial design and follow-up, as well as postoperative strategy-making.
III 期 N2 期非小细胞肺癌(NSCLC)患者的术后生存存在高度异质性。本研究旨在确定与术后生存相关的变量,并开发一种用于生存预测的工具。
回顾性分析 2004 年 1 月至 2009 年 12 月期间监测、流行病学和最终结果(SEER)数据库中的数据。使用向后逐步法选择有意义的变量。采用多变量 Cox 回归构建列线图。通过一致性指数和校准曲线评估模型的性能。使用来自江苏省肿瘤医院肺癌中心的独立队列验证模型。
共纳入 1809 例接受手术治疗的 IIIA-N2 期 NSCLC 患者作为训练队列。使用向后逐步法确定年龄、性别、分级、组织学类型、肿瘤大小、脏层胸膜侵犯、阳性淋巴结、淋巴结检查数和手术类型(肺叶切除术与全肺切除术)为显著预后变量。从训练队列中建立了列线图,并使用中国独立队列进行验证。模型在训练队列中的一致性指数为 0.673(95%置信区间,0.654-0.692),在验证队列中为 0.664(95%置信区间,0.614-0.714)。校准图显示列线图预测的生存与观察生存之间存在最佳一致性。生存分析显示,根据预后评分分层的不同亚组之间存在显著差异。
该列线图为接受手术治疗的 IIIA-N2 期 NSCLC 患者提供了个体生存预测,这可能有助于为患者和临床医生提供生存咨询、临床试验设计和随访以及术后策略制定。